ClinicalTrials.gg
RecruitingNCT04886245EyeTrackingFPUpdated Oct 16, 2026

Eye-Tracking FP "A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.

An interventional study of Video sequences in Eye-tracking and Facial Palsy, sponsored by Centre Hospitalier Universitaire, Amiens. Recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Centre Hospitalier Universitaire, Amiens · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Jan 2020, registered May 2021).
  • Started Jan 2020; still recruiting 6 years 9 months later.
Updated Oct 16, 2026Start date movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The facial palsy concerns between 15 and 40 people per 100000 inhabitants. They are of various etiologies such as infectious, tumoral, traumatic or idiopathic.

It has variable severities with sometimes heavy functional repercussions and different recovery potentials. The proposed palliative treatments are based on surgery, physiotherapy and botulinum toxin injections. However, when recovery is incomplete, acceptance is more difficult, with an impacted quality of life. In this context, patients' expectations and feelings about their care may become difficult for clinicians to apprehend.

The eye-tracking is widely used in the marketing field, but it also finds medical applications including head and neck lesions and facial palsy in particular. Published studies focus on the gaze of photographs, excluding any notion of dynamics and by the analysis of the gaze of outside observers, ignoring the patient's gaze.The main objective is to evaluate the attention paid to the facial side with abnormal facial movement by patients with facial paralysis compared to healthy volunteers.

02

Conditions studied

  • Eye-tracking
  • Facial Palsy

Browse trials for

Keywords

  • facial mimics
  • eye-tracking
  • Facial Palsy
03

In context

Facial Paralysis

81 studies on the registry are indexed under Facial Paralysis; 28 are open to participants now.

This study's planned enrollment of 60 is above the median of 50 across 59 interventional studies indexed under Facial Paralysis.

Browse Facial Paralysis studies →

Lead sponsor

Centre Hospitalier Universitaire, Amiens is the lead sponsor of 586 studies on the registry; 185 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • for patient with facial paralysis:
  • Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated
  • Patient providing written
  • Patient aged ≥ 18 years
  • Patient affiliated to a social security system
  • for Healthy voluntary subject :
  • Subject without major facial sequelae
  • Subject who provided written informed consent
  • Major subject ≥ 18 years old
  • Subject affiliated to a social security system

Exclusion criteria

Exclusion Criteria:

  • for Patient with facial paralysis:
  • Patient with recent peripheral facial palsy whose total recovery is possible
  • Patient unable to provide written
  • Patient with difficulties to follow instructions and especially to stand in front of a computer screen
  • Minor patient \<18 years
  • Patient under guardianship or curators or judicial safeguard
  • for Healthy voluntary subject :
  • Subject with major facial sequelae
  • Subject not able to provide written informed consent
  • Subject presenting difficulties in following instructions and in particular in standing still in front of a computer screen
  • Minor subject \< 18 years old
  • Subject under guardianship or curators or judicial safeguard
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    facial palsy

    Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated

    Other: Video sequences

  • Sham comparator
    healthy volunteers

    \- Subject without major facial sequelae

    Other: Video sequences

Interventions

  • OtherVideo sequences

    videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound \[o\], the labial protrusion on the sound \[pu\] and the wide smile uncovering the teeth. Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.

06

What researchers measure

Primary outcomes

  1. Variation of facial fixation day number between facial palsy patients and healthy volunteers

    Time frame: 30 days

  2. Incidence of facial movement abnormality between facial palsy patients and healthy volunteers

    Time frame: 30 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Start date
May 6, 2021→Jan 31, 2020
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Start date May 6, 2021→Jan 31, 2020
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04886245
Responsible party
Sponsor
First posted
May 14, 2021
Start date
Jan 31, 2020
Primary completion
Jul 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Oct 16, 2026

Study contacts

Stéphanie DAKPE, PR
Contact
dakpe.stephanie@chu-amiens.fr
03.22.08.90.50
Sylvie TESTELIN
Contact
testelin.sylvie@chu-amiens.fr
03.22.08.90.50

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion